lamivudine refractory patients

Related by string. * Lamivudine : 3TC lamivudine Epivir . abacavir sulfate lamivudine . zidovudine lamivudine . lamivudine zidovudine / Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML / pa tients . PATIENTS . PATIENT : Breast Cancer Patients . terminally ill patients . Patient Safety * *

Related by context. Frequent words. (Click for all words.) 68 HCV genotype 1 67 plus methotrexate 65 plus ribavirin 64 mg BID 64 HCV infected 63 virologic response 63 leukopenia 63 mg QD 63 virologic failure 63 entecavir 62 sustained virologic response 62 mg kg dose 62 metastatic renal cell carcinoma 62 adefovir 62 interferon alfa 61 peginterferon 61 peginterferon alfa 2a 61 lamivudine 61 peginterferon alfa 2b 61 FOLFIRI 61 azathioprine 61 evaluable 61 median PFS 60 hypokalemia 60 confidence interval #.#-#.# 60 adalimumab 60 plus prednisone 60 noninferiority 60 tocilizumab 60 patients receiving ERBITUX 60 lopinavir ritonavir 60 % CI #.#-#.# [006] 60 NRTI 60 decitabine 60 raltegravir 60 febrile neutropenia 60 linezolid 60 severe renal impairment 60 mcg kg 59 renal insufficiency 59 statistically significant p 59 undetectable viral load 59 tenofovir disoproxil fumarate 59 lopinavir 59 nonresponders 59 dacarbazine 59 relapsed multiple myeloma 59 chronic HCV 59 evaluable patients 59 creatinine clearance 59 hypomagnesemia 59 ketoconazole 58 bosentan 58 chronic HCV infection 58 Trastuzumab 58 enalapril 58 tipranavir 58 placebo p = 58 plus gemcitabine 58 HbA1c levels 58 Chronic Hepatitis C 58 ADAS cog 58 vinorelbine 58 LEXIVA 58 n = 58 castration resistant prostate cancer 58 nitazoxanide 58 peg IFN 58 HBV DNA 58 abatacept 58 teriparatide 58 temsirolimus 57 ziprasidone 57 P = .# 57 administered subcutaneously 57 pg mL 57 darunavir 57 relapsed refractory 57 NNRTIs 57 NNRTI 57 anti TNF 57 telbivudine 57 cytogenetic response 57 dose cohorts 57 sunitinib 57 active comparator 57 infliximab 57 QTc 57 laboratory abnormalities 57 relapsed refractory multiple myeloma 57 atazanavir 57 T#I mutation 57 chronic lymphocytic leukemia CLL 57 methotrexate MTX 57 events AEs 57 EGFR inhibitors 57 HER2 positive metastatic breast 57 hypocalcemia 57 lamotrigine 57 pegylated interferon 57 antiviral therapy

Back to home page